Skip to content

13F-HR filed by Commodore Capital LP

Commodore Capital LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 35 holding rows worth $663,544,000.

Accession
0001831942-23-000005
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 35 entries on the cover page, a total value of $663,544,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $663,544,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
XENON PHARMACEUTICALS INC COM98420N105Stock1,659,111$65,419,000thousands, detected and multiplied
VIRIDIAN THERAPEUTICS INC92790C104COM2,020,166$59,009,000thousands, detected and multiplied
COGENT BIOSCIENCES INC19240Q201COM4,319,940$49,939,000thousands, detected and multiplied
BELLUS HEALTH INC NEW07987C204COM5,303,557$43,595,000thousands, detected and multiplied
MERUS N VN5749R100COM2,732,567$42,273,000thousands, detected and multiplied
CYMABAY THERAPEUTICS INC23257D103COM5,738,500$35,980,000thousands, detected and multiplied
ACLARIS THERAPEUTICS INC COM00461U105Stock1,880,286$29,615,000thousands, detected and multiplied
AKERO THERAPEUTICS INC00973Y108COM537,076$29,432,000thousands, detected and multiplied
NUVALENT INC COM670703107Stock913,621$27,208,000thousands, detected and multiplied
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW495,823$22,099,000thousands, detected and multiplied
IMMUNOVANT INC45258J102COM1,150,505$20,421,000thousands, detected and multiplied
ARROWHEAD PHARMACEUTICALS IN04280A100COM462,111$18,743,000thousands, detected and multiplied
CELCUITY INC15102K100COM1,327,952$18,605,000thousands, detected and multiplied
ARCELLX INC COMMON STOCK03940C100Stock591,437$18,323,000thousands, detected and multiplied
SYNDAX PHARMACEUTICALS INC87164F105COM688,445$17,521,000thousands, detected and multiplied
Day One Biopharmaceuticals Inc23954D109Common Stock739,661$15,918,000thousands, detected and multiplied
PROMETHEUS BIOSCIENCES INC74349U108COM127,156$13,987,000thousands, detected and multiplied
ALLAKOS INC01671P100COM1,643,500$13,838,000thousands, detected and multiplied
KURA ONCOLOGY INC COM50127T109Stock1,099,407$13,644,000thousands, detected and multiplied
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock598,385$13,290,000thousands, detected and multiplied
AVIDITY BIOSCIENCES INC COM05370A108Stock590,705$13,108,000thousands, detected and multiplied
ENANTA PHARMACEUTICALS INC29251M106COM223,494$10,397,000thousands, detected and multiplied
IMARA INC45249V107COM2,494,794$10,204,000thousands, detected and multiplied
ALPINE IMMUNE SCIENCES INC02083G100COM1,325,000$9,739,000thousands, detected and multiplied
89BIO INC282559103COM758,244$9,652,000thousands, detected and multiplied
CABALETTA BIO INC12674W109COMMON STOCK1,010,359$9,346,000thousands, detected and multiplied
VAXCYTE INC COM92243G108Stock173,481$8,318,000thousands, detected and multiplied
KARYOPHARM THERAPEUTICS INC48576U106COM1,935,609$6,581,000thousands, detected and multiplied
THIRD HARMONIC BIO INC88427A107COM993,294$4,271,000thousands, detected and multiplied
LARIMAR THERAPEUTICS INC517125100COM750,000$3,098,000thousands, detected and multiplied
ACUMEN PHARMACEUTICALS INC00509G209CMN498,315$2,691,000thousands, detected and multiplied
IMMUNIC INC4525EP101COM1,800,000$2,520,000thousands, detected and multiplied
REZOLUTE INC76200L309COMMON STOCK1,210,000$2,505,000thousands, detected and multiplied
KALVISTA PHARMACEUTICALS INC483497103COM312,553$2,113,000thousands, detected and multiplied
DBV TECHNOLOGIES S A23306J101ADR92,687$142,000thousands, detected and multiplied

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001831942-23-000005this filing2023-02-14acceptance time not in the bulk data set